AnalystsMatthew BieglerMatthew Biegler's Stock Forecasts
AnalystsMatthew Biegler
Sectors:
Industries:
Analyst Ranking
Bottom 3%
#4766 out of 4873 analysts
Average Return
-20.88%
Win Rate
27%21 out of 78
Risk vs Reward
Poor
Good
Matthew Biegler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fate Therapeutics IncFATE | +222.98% | $24.80 | $80.10 | 2020-04-05 - 2021-04-06 | Buy |
Oric Pharmaceuticals IncORIC | +202.61% | $4.99 | $15.10 | 2023-03-15 - 2024-03-15 | Buy |
Aptose Biosciences IncAPTOF | +189.86% | $931.51 | $2,700.04 | 2019-01-24 - 2020-01-24 | Buy |
Ideaya Biosciences IncIDYA | +138.55% | $10.74 | $25.62 | 2022-08-15 - 2023-08-15 | Buy |
Fulcrum Therapeutics IncFULC | +117.11% | $3.80 | $8.25 | 2023-05-15 - 2024-05-15 | Buy |
Matthew Biegler Analyst Color
Get additional color on Matthew Biegler's coverage of popular stocks
Matthew Biegler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Oric Pharmaceuticals IncORIC | 5 | Buy | $12.00 | +125.56% | Maintains | 3 days ago |
Vor Biopharma IncVOR | 7 | Buy | $8.00 | +4,900.00% | Reiterates | 2 months ago |
Olema Pharmaceuticals IncOLMA | 5 | Buy | $25.00 | +435.33% | Reiterates | 2 months ago |
Arvinas IncARVN | 4 | Buy | $45.00 | +560.79% | Maintains | 3 months ago |
Gilead Sciences IncGILD | 1 | Buy | $115.00 | +17.16% | Reiterates | 5 months ago |
Ideaya Biosciences IncIDYA | 5 | Buy | $53.00 | +191.53% | Reiterates | 6 months ago |
Tyra Biosciences IncTYRA | 6 | Buy | $33.00 | +227.71% | Maintains | 8 months ago |
Zentalis Pharmaceuticals IncZNTL | 7 | Buy | $20.00 | +1,487.30% | Reiterates | 8 months ago |
Allogene Therapeutics IncALLO | 1 | Buy | $11.00 | +832.20% | Assumes | 9 months ago |
Relay Therapeutics IncRLAY | 5 | Buy | $24.00 | +700.00% | Maintains | 9 months ago |
Blueprint Medicines CorpBPMC | 5 | Buy | $125.00 | +26.57% | Maintains | 10 months ago |
Cartesian Therapeutics IncRNAC | 3 | Buy | $50.00 | +379.85% | Reiterates | 10 months ago |
Fulcrum Therapeutics IncFULC | 5 | Buy | $14.00 | +158.78% | Maintains | a year ago |
Alpine Immune Sciences IncALPN | 1 | Buy | $44.00 | N/A | Reiterates | a year ago |
Medicenna Therapeutics CorpMDNAF | 3 | Buy | $3.00 | N/A | Maintains | 2 years ago |
Aptose Biosciences IncAPTOF | 5 | Buy | $450.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 2 years ago |
Acrivon Therapeutics IncACRV | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Portage Biotech IncPRTG | 1 | Buy | $360.00 | N/A | Maintains | 2 years ago |
Nkarta IncNKTX | 2 | Buy | $36.00 | N/A | Maintains | 2 years ago |
Celularity IncCELU | 1 | Buy | $90.00 | N/A | Initiates Coverage On | 3 years ago |
Turning Point Therapeutics IncTPTX | 3 | Buy | $105.00 | N/A | Maintains | 3 years ago |
Fate Therapeutics IncFATE | 1 | Buy | $34.00 | N/A | Maintains | 5 years ago |
Q32 Bio IncQTTB | 1 | Buy | $576.00 | N/A | Upgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.